Back to Search
Start Over
Low-intensity pulsed ultrasound therapy suppresses coronary adventitial inflammatory changes and hyperconstricting responses after coronary stent implantation in pigs in vivo
- Source :
- PLoS ONE, PLoS ONE, Vol 16, Iss 9, p e0257175 (2021)
- Publication Year :
- 2021
-
Abstract
- Backgrounds We demonstrated that coronary adventitial inflammation plays important roles in the pathogenesis of drug-eluting stent (DES)-induced coronary hyperconstricting responses in pigs in vivo. However, no therapy is yet available to treat coronary adventitial inflammation. We thus developed the low-intensity pulsed ultrasound (LIPUS) therapy that ameliorates myocardial ischemia by enhancing angiogenesis. Aims We aimed to examine whether our LIPUS therapy suppresses DES-induced coronary hyperconstricting responses in pigs in vivo, and if so, what mechanisms are involved. Methods Sixteen normal male pigs were randomly assigned to the LIPUS or the sham therapy groups after DES implantation into the left anterior descending (LAD) coronary artery. In the LIPUS group, LIPUS (32 cycles, 193 mW/cm2) was applied to the heart at 3 different levels (segments proximal and distal to the stent edges and middle of the stent) for 20 min at each level for every other day for 2 weeks. The sham therapy group was treated in the same manner but without LIPUS. At 4 weeks after stent implantation, we performed coronary angiography, followed by immunohistological analysis. Results Coronary vasoconstricting responses to serotonin in LAD at DES edges were significantly suppressed in the LIPUS group compared with the sham group. Furthermore, lymph transport speed in vivo was significantly faster in the LIPUS group than in the sham group. Histological analysis at DES edges showed that inflammatory changes and Rho-kinase activity were significantly suppressed in the LIPUS group, associated with eNOS up-regulation and enhanced lymph-angiogenesis. Conclusions These results suggest that our non-invasive LIPUS therapy is useful to treat coronary functional abnormalities caused by coronary adventitial inflammation, indicating its potential for the novel and safe therapeutic approach of coronary artery disease.
- Subjects :
- Swine
Cardiovascular Procedures
Physiology
medicine.medical_treatment
Low-intensity pulsed ultrasound
Cardiovascular Medicine
Biochemistry
Vascular Medicine
Muscle, Smooth, Vascular
Pathogenesis
Coronary artery disease
Medical Conditions
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
Medicine and Health Sciences
Coronary Heart Disease
Lymphangiogenesis
Immune Response
Coronary Arteries
Mammals
rho-Associated Kinases
Multidisciplinary
Eukaryota
Drug-Eluting Stents
Neurochemistry
Neurotransmitters
Arteries
Coronary Vessels
Body Fluids
medicine.anatomical_structure
Ultrasonic Waves
Cardiovascular Diseases
Vertebrates
Cardiology
Medicine
Lymph
medicine.symptom
Anatomy
Artery
Research Article
medicine.medical_specialty
Adventitia
Serotonin
Biogenic Amines
Coronary Stenting
Science
Myocytes, Smooth Muscle
Immunology
Inflammation
Surgical and Invasive Medical Procedures
Models, Biological
Blood Vessel Prosthesis Implantation
Signs and Symptoms
In vivo
Internal medicine
Coronary stent
medicine
Animals
Lymphatic Vessels
business.industry
Organisms
Stent
Biology and Life Sciences
medicine.disease
Enzyme Activation
Vasoconstriction
Stent Implantation
Amniotes
Cardiovascular Anatomy
Blood Vessels
Clinical Medicine
business
Zoology
Neuroscience
Subjects
Details
- ISSN :
- 19326203
- Volume :
- 16
- Issue :
- 9
- Database :
- OpenAIRE
- Journal :
- PloS one
- Accession number :
- edsair.doi.dedup.....e0716c61a14084058ca15b982a0e42f5